Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) (345317)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

This grant supports the development of a comprehensive understanding of the impact of sex differences on brain aging and disease trajectories, particularly focusing on Alzheimer's disease (AD) and AD-related dementias (ADRD). It aims to employ integrative experimental and analytical approaches combining basic and translational/clinical research. The grant encourages the exploration of how genes, environment, and host factors, including hormonal status, influence disease risk and treatment response. The ultimate goal is to advance research programs that produce heterogeneous disease risk phenotypes and improve prevention and therapy for AD/ADRD through understanding sex differences.

Eligibility

Organization's Location
voluptate ipsum
Program Location
reprehenderit
Organization Type
not specified

Submission

Schedule
Step 1: proident ut nisi
Application deadline
Nov 12, 2024
Step 2: Lorem nostrud (incididunt dolore)

Similar grants